Regen BioPharma Inc (RGBP): Form 8-K filed 2026-07-15

Items reported

Item 1.01: Entry into a Material Definitive Agreement
The company signed a material agreement outside the ordinary course of business, or materially amended one. Typical examples are credit agreements, merger agreements, large supply or licensing contracts and financing arrangements.
Item 4.01: Changes in Registrant's Certifying Accountant
The company's independent auditor resigned, declined to stand for re-appointment or was dismissed, or a new auditor was engaged. The company must disclose any disagreements or reportable events.
Item 8.01: Other Events
A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news.
Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.

This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.